Fust Matthew K Insider Trades

Insider Trading History

Track insider trading activity for Fust Matthew K. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $139k 80,000 shares
Last Trade
May 27, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$149k 80,000 shares
$1.86
$1.74
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $755k 33,696 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$563k 21,809 shares
$25.80
$22.41
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $69.2k 2,092 shares
Last Trade
Sep 26, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$459k 10,000 shares
$45.91
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $756k 22,836 shares
Last Trade
Sep 26, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$716k 16,000 shares
$44.75
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $1.29M 38,836 shares
Last Trade
Sep 26, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$459k 10,000 shares
$45.91
$33.09
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $954k 28,836 shares
Last Trade
Jun 11, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$335k 10,350 shares
$32.33
$33.09
Atara Biotherapeutics
Atara Biotherapeutics ATRA
Director
Holding Value $175k 18,188 shares
Last Trade
Jun 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$71.4k 7,828 shares
$9.12
$9.63
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $149k 85,586 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$160k 221,959 shares
$0.72
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $0 0 shares
Last Trade
May 28, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$20.4k 28,571 shares
$0.72
$1.74
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $581k 25,945 shares
Last Trade
May 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$376k 10,787 shares
$34.84
$22.41
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $0 0 shares
Last Trade
Feb 13, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$240k 141,959 shares
$1.69
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $149k 85,586 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$240k 141,959 shares
$1.69
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $59.4k 34,149 shares
Last Trade
Oct 18, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$232k 14,049 shares
$16.49
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $149k 85,586 shares
Last Trade
Oct 18, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$232k 14,049 shares
$16.49
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $35k 20,100 shares
Last Trade
Oct 18, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$239k 14,049 shares
$17.03
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $48.4k 27,839 shares
Last Trade
Oct 17, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$131k 7,739 shares
$16.96
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $35k 20,100 shares
Last Trade
Oct 17, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$132k 7,739 shares
$17.01
$1.74
Neumora Therapeutics
Neumora Therapeutics NMRA
Director
Holding Value $163k 93,430 shares
Last Trade
Oct 17, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$131k 7,739 shares
$16.96
$1.74
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical RARE
Director
Holding Value $453k 20,205 shares
Last Trade
Jun 18, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$370k 9,900 shares
$37.42
$22.41
Crinetics Pharmaceuticals
Crinetics Pharmaceuticals CRNX
Director
Holding Value $726k 21,936 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$559k 12,500 shares
$44.71
$33.09

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up